<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease is recognized as a <z:e sem="disease" ids="C0559758" disease_type="Disease or Syndrome" abbrv="">multisystem disorder</z:e> that affects mainly young adults in Mediterranean, Middle Eastern, and Far Eastern countries </plain></SENT>
<SENT sid="1" pm="."><plain>The diagnosis is very difficult because there is no laboratory test </plain></SENT>
<SENT sid="2" pm="."><plain>Clinical features - such as orogenital aphtae, ocular and <z:mp ids='MP_0001212'>skin lesions</z:mp>, <z:hpo ids='HP_0001369'>arthritis</z:hpo>, and neurologic, gastrointestinal, vascular, and pulmonary symptoms - are helpful for diagnosis </plain></SENT>
<SENT sid="3" pm="."><plain>Various cardiovascular manifestations, such as <z:e sem="disease" ids="C0030270" disease_type="Disease or Syndrome" abbrv="">pancarditis</z:e>, <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, conduction system disturbances, and valvular diseases, have been reported but are rare </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0876998" disease_type="Disease or Syndrome" abbrv="">Intracardiac thrombus</z:e> formation, as seen in our patients, is exceptional even among cardiovascular cases of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's </plain></SENT>
<SENT sid="5" pm="."><plain>OBSERVATIONS: We report three cases of intracardiac <z:mp ids='MP_0005048'>thrombosis</z:mp> among 204 patients followed for <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease within our unit over a period of 7 years </plain></SENT>
<SENT sid="6" pm="."><plain>We report outcomes after <z:chebi fb="0" ids="50858">corticosteroid</z:chebi>, <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, and oral <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy </plain></SENT>
<SENT sid="7" pm="."><plain>DISCUSSION: Cardiovascular involvement has been reported in 7 % to 29 % of patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's syndrome </plain></SENT>
<SENT sid="8" pm="."><plain>Intracardiac <z:mp ids='MP_0005048'>thrombosis</z:mp> is extremely rare and the right heart is the most common site of involvement </plain></SENT>
<SENT sid="9" pm="."><plain>The first symptoms and signs of the disease frequently precede systemic organ manifestations </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Diagnosis of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease might be considered if a patient presents with a mass in the right-sided cardiac chambers, even in the absence of the characteristic clinical features of the condition </plain></SENT>
<SENT sid="11" pm="."><plain>This is particularly applicable if the patient is a young male from the Mediterranean basin or the Middle East </plain></SENT>
<SENT sid="12" pm="."><plain>We suggest that the treatment could include <z:chebi fb="0" ids="23359">colchicine</z:chebi>, <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy, and <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> and discuss immunosuppressive therapy </plain></SENT>
</text></document>